Norges Bank Makes New $1.55 Million Investment in Ardent Health Partners, LLC (NYSE:ARDT)

Norges Bank bought a new position in shares of Ardent Health Partners, LLC (NYSE:ARDT - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 90,645 shares of the company's stock, valued at approximately $1,548,000. Norges Bank owned about 0.06% of Ardent Health Partners as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. State Street Corp purchased a new stake in Ardent Health Partners in the 3rd quarter valued at about $1,977,000. Jane Street Group LLC purchased a new stake in shares of Ardent Health Partners in the 3rd quarter valued at approximately $567,000. Barclays PLC purchased a new stake in shares of Ardent Health Partners in the 3rd quarter valued at approximately $385,000. Geode Capital Management LLC acquired a new position in shares of Ardent Health Partners in the 3rd quarter worth approximately $2,581,000. Finally, JPMorgan Chase & Co. purchased a new position in shares of Ardent Health Partners during the 3rd quarter worth approximately $154,000.

Ardent Health Partners Trading Down 0.4 %

Shares of ARDT stock traded down $0.06 on Tuesday, reaching $12.37. 417,711 shares of the stock were exchanged, compared to its average volume of 407,059. The business's 50 day moving average price is $13.81 and its 200 day moving average price is $15.70. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. Ardent Health Partners, LLC has a twelve month low of $11.60 and a twelve month high of $20.72.

Remove Ads

Ardent Health Partners (NYSE:ARDT - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.81 EPS for the quarter, beating analysts' consensus estimates of $0.50 by $0.31. The business had revenue of $1.61 billion during the quarter, compared to analysts' expectations of $1.48 billion. As a group, analysts expect that Ardent Health Partners, LLC will post 1.23 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. Truist Financial decreased their price target on Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. Morgan Stanley lowered their target price on Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating for the company in a report on Tuesday, January 21st. Mizuho cut their price target on shares of Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 9th. Royal Bank of Canada lowered their price objective on shares of Ardent Health Partners from $23.00 to $21.00 and set an "outperform" rating for the company in a research note on Tuesday, March 4th. Finally, Stephens reiterated an "overweight" rating and set a $22.00 target price on shares of Ardent Health Partners in a report on Tuesday, April 1st. Two equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Buy" and a consensus target price of $20.58.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.